Structural OCT Parameters Associated with Treatment Response and Macular Neovascularization Onset in Central Serous Chorioretinopathy.
Source check: Source checked. Not independent scientific confirmation.
Finding: In a 96-eye, 36-month prospective CSC series, a decision-tree/logistic analysis associated OCT features and age with treatment response and MNV onset. The associations are cohort-specific and do not establish which treatment causes better outcomes.
Technology: a supervised decision-tree approach uses OCT measurements, hyperreflective foci, age and sex to associate imaging features with treatment response; logistic modeling analyzes MNV onset.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- a supervised decision-tree approach uses OCT measurements, hyperreflective foci, age and sex to associate imaging features with treatment response; logistic modeling analyzes MNV onset.
- Test and result
- among 96 treatment-naive eyes followed for 36 months, OCT hyperreflective foci and age were associated with response to eplerenone/PDT; retinal/RPE/choroidal parameters were associated with MNV risk.
- Limitation / still unknown
- The result is tied to prospectively observed clinical/OCT/angiography outcomes through 36 months in one case series. No held-out or external model validation is reported; approval is limited to these cohort associations, not treatment-selection performance or causal benefit.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC8079563/ · https://pubmed.ncbi.nlm.nih.gov/33606200/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.